Cosmetic Compliance
Intelligence & Solutions

Live Panel Discussion: Decoding the Cosmetic Regulation Differences In ASEAN

FREE
Agatha Della, Angelita Hu, Diego Sala, Julia Ji
Thursday , 15th Jul 2021
Background

On 2 September 2003, ASEAN Ministers signed the Agreement on the ASEAN Harmonized Cosmetic Regulatory Scheme (AHCRS) to enhance cooperation amongst the member states in ensuring the safety, quality and claimed benefits of all cosmetic products marketed in ASEAN and eliminate restrictions on cosmetic trade amongst Member States. Although the objective of AHCRS is to harmonize the cosmetic regulations within the region, there are some regulatory differences in the actual implementation of the scheme in the ASEAN member states, especially Indonesia and Thailand, such as:

  • The term "notification" in regulation is basically regarded as informing the government that the company will place the product on the market. However, in Indonesia, it is the pre-approval companies need to obtain before entering the market;

  • In Thailand, some claims are specifically forbidden: the term "eraser" is forbidden for anti-aging products and the term "restructure" is authorized only hairstyling products);

  • The requirements for documentation and information could vary greatly. Companies are not required to submit product formula information when they want to enter the Singapore market. But Indonesian authorities require companies to declare all formula ingredients as well as the percentage of each ingredient.

During the panel discussion, Angelita Hu, regulatory analyst at ChemLinked, will firstly introduce an overview of the ASEAN cosmetic regulations. Then Julia Ji, Agatha Della and Diego Sala, regulatory experts from Singapore, Indonesia and Thailand respectively will share the key differences in cosmetic notification requirements, the limitation or use condition of ingredients, import certificates post-market surveillance, etc.

Contents

Topics:

  • Regarding the requirement for cosmetic notification, are there any differences between your country's scheme and the overall ASEAN scheme?

  • Regarding the limitation or use condition of ingredients, are there any typical differences compared with the annexes of ASEAN Cosmetic Directive (ACD)?

  • Are there any other noteworthy differences or special requirements in your country?

Contact Information

If you have any questions about this webinar, please contact us at:

EMAIL: contact@chemlinked.com

TEL: +86 571 8609 4444

Speaker
  • Business Consultant of Cekindo
    Agatha Della is the business consultant and also Chinese business development coordinator in Cekindo Business International. One of her main roles in Cekindo is to help foreign investors interested in investing in Indonesia understand any government regulations related to their business, and provide professional consulting services. Previously she worked in international trade companies in Indonesia and Taiwan, with more than 5 years of experience in business development and customer relation.
  • ChemLinked Regulatory Analyst
    Angelita Hu is the managing editor and regulatory analyst of ChemLinked Cosmetic Portal. She focuses on reporting and interpreting regulatory updates in China, ASEAN and the rest of the Asia Pacific region, promoting and implementing the regulatory content innovation and finding global partners to co-build a content ecosystem. With over 5 years of work experience at ChemLinked, she has gained extensive knowledge of cosmetic regulations and market entry and an in-depth understanding of the cosmetic industry.
  • Managing Director
    Diego Sala oversees the activity of General Manager, and he’s direct responsible of new projects in start-up phase. He supervises the activity of Regulatory in his company, being the direct responsible of Dietary Supplement and Medical Devices. Diego is graduated at University of Genoa, Italy, and have 20 years experience in International Commerce worldwide. He emphasizes on the humanistic values at the center of every activity: people make the company, company makes the market.
  • Director/Founder of MyAssociates
    Before setting up her own consulting firms, she worked for Health Sciences Authority (HSA) Singapore as Regulatory Consultant/Acting Deputy Director for Complementary Health Product Branch (CHPB). She has gained insights of government thinking for regulating health products and skills for managing regulatory professional teams, scientific and regulatory database, as well as skills for professional cooperation and communication with government agencies and industry leaders at international, regional and local levels.